InvestorsHub Logo
Followers 8
Posts 1924
Boards Moderated 0
Alias Born 09/10/2012

Re: None

Monday, 11/22/2021 3:03:55 AM

Monday, November 22, 2021 3:03:55 AM

Post# of 326
OBSEVA ANNOUNCES U.S. FDA ACCEPTANCE OF NEW DRUG APPLICATION FOR LINZAGOLIX
FDA SET A TARGET ACTION DATE OF SEPTEMBER 13, 2022 FOR THIS NDA UNDER PRESCRIPTION DRUG USER FEE ACT (PDUFA)
LINZAGOLIX MARKETING AUTHORIZATION APPLICATION WAS VALIDATED BY EMA FOR HUMAN USE (CHMP) EXPECTED IN Q4 2021
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent OBSV News